Goudreau, JL, Burau K, Perez A, Aminoff, M, Bodis-Wollner, I, Fang, J, Tilley B for the NET-PD Investigators. Initial choice of dopaminergic therapy in the NINDS Exploratory Trials in Parkinson Disease (NET-PD) Longitudinal Study-1 (LS-1). Arch Neurol, submitted, 2013.
Benskey, MJ, Lee, KY, Parikh K, Lookingland, KJ, Goudreau, JL. Resistance to acute MPTP toxicity by hypothalamic dopamine neurons following chronic neurotoxicant exposure is associated with sustained up-regulation of parkin protein. Neurotoxiology, in press, 2013.
Tiernan CT, Edwin EA, Goudreau JL, Atchison WD, Lookingland KJ. The Role of De Novo Catecholamine Synthesis in Mediating Methylmercury-Induced Vesicular Dopamine Release from Rat Pheochromocytoma (PC12) Cells. Toxicol Sci. 2013 Mar 15. [Epub ahead of print] PubMed PMID: 23425605.
Hsu SC, Sears RL, Lemos RR, Quintáns B, Huang A, Spiteri E, Nevarez L, Mamah C, Zatz M, Pierce KD, Fullerton JM, Adair JC, Berner JE, Bower M, Brodaty H, Carmona O, Dobricić V, Fogel BL, García-Estevez D, Goldman J, Goudreau JL, Hopfer S, Janković M, Jaumà S, Jen JC, Kirdlarp S, Klepper J, Kostić V, Lang AE, Linglart A, Maisenbacher MK, Manyam BV, Mazzoni P, Miedzybrodzka Z, Mitarnun W, Mitchell PB, Mueller J, Novaković I, Paucar M, Paulson H, Simpson SA, Svenningsson P, Tuite P, Vitek J, Wetchaphanphesat S, Williams C, Yang M, Schofield PR, de Oliveira JR, Sobrido MJ, Geschwind DH, Coppola G. Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification. Neurogenetics. 14(1):11-22, 2013. PubMed PMID: 23334463.
Elm JJ; NINDS NET-PD Investigators. Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1. Mov Disord. 2012 27(12):1513-21, 2012. PubMed Central PMCID: PMC3481179. PMID: 23079770
Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, Crystal RG, Darnell RB, Ferrante RJ, Fillit H, Finkelstein R, Fisher M, Gendelman HE, Golub RM, Goudreau JL, Gross RA, Gubitz AK, Hesterlee SE, Howells DW, Huguenard J, Kelner K, Koroshetz W, Krainc D, Lazic SE, Levine MS, Macleod MR, McCall JM, Moxley RT 3rd, Narasimhan K, Noble LJ, Perrin S, Porter JD, Steward O, Unger E, Utz U, Silberberg SD. A call for transparent reporting to optimize the predictive value of preclinical research. Nature; 490(7419):187-91, 2012.
Simkins TJ, Janis KL, McClure AK, Behrouz B, Pappas SJ, Lehner A, Kaminski N, Goudreau JL, Lookingland KJ, Kaplan BL. Comparison of the D2 receptor regulation of neurotoxicant susceptibility of nigrostriatal dopamine neurons in wild-type and CB1/CB2 receptor knockout mice. J Neuroimm Pharm, 7(3):533-538, 2012.
Benskey M, Behrouz B, Sunryd J, Pappas SS, Baek SH, Huebner M, Lookingland KJ, Goudreau JL. Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression. Neurotoxicology. 33(3):321-331, 2012.
Lee KY, Bae ON, Serfozo K, Hejabian S, Moussa A, Reeves M, Rumbeiha W, Fitzgerald SD, Stein G, Baek SH, Goudreau J, Kassab M, Majid A. Asiatic Acid Attenuates Infarct Volume, Mitochondrial Dysfunction, and Matrix Metalloproteinase-9 Induction After Focal Cerebral Ischemia. Stroke. 43(6):1632-8, 2012. PMCID: PMC3361557 PMID: 22511009.
Ravizza SM, Goudreau J, Delgado MR, Ruiz S. Executive function in Parkinson's disease: contributions of the dorsal frontostriatal pathways to action and motivation. Cogn Affect Behav Neurosci. 12(1):321-331, 2011 PMID: 22006555.
Pappas, S., Kennedy, T., Goudreau, J.L., Lookingland, K.J., Opioid-mediated regulation of A11 diencephalospinal dopamine neurons: pharmacological evidence of activation by morphine, Neurpharmacology, 2011, Neuropharmacology;61(4):614-21, 2011.
Parkinson Study Group PramiBID Investigators, Twice daily, low-dose pramipexole in early Parkinon’s disease: A randomized, placebo-controlled trial, Movement Disorders, 26:37-55, 2011.
Lerner, A., Johnson, Simkins T.J., Janis K.L., Lookingland, K.J., Goudreau, J.L., Rumbieha, W. Liquid Chromatographic—Electrospray Mass Spectrometric Determination of 1-Methyl-4-phenylpyridine (MPP+) in Discrete Regions of Murine Brain. Toxicology Mech Methods, 21:171-182, 2011.
Olanow CW, Rascol O, Hauser R, Feigin PD, Jankovic J, Lang A, Langston W, Melamed E, Poewe W, Stocchi F, Tolosa E; ADAGIO Study Investigators. A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Engl J Med. 2009 Sep 24;361(13):1268-78.
Han D, Yang B, Olson LK, Greenstein A, Baek SH, Claycombe KJ, Goudreau JL, Yu SW, Kim EK; Activation of autophagy through modulation of amp-activated protein kinase protects pancreatic beta-cells from hyperglycemia, Biochemical J., 425:541:-551, 2010.
Pappas SS, Tiernan, CT, Behrouz, B, Jordan C, Breedlove SM, Goudreau, JL, Lookingland KJ. Neonatal androgen-dependent sex differences in lumbar spinal cord dopamine concentrations and the number of A11 diencephalospinal dopamine neurons. J Comp Neurol, 518:2423-2436, 2010.
Baek SH, Kim EK, Goudreau JL, Lookingland KJ, Kim SW, Yu SW. Insulin withdrawal-induced cell death in adult hippocampal neural stem cells as a model of autophagic cell death. Autophagy, 5:277-9, 2009
Krishnamurthy RG, Senut MC, Zemke D, Min J, Frenkel MB, Greenberg EJ, Yu SW, Ahn N, Goudreau J, Kassab M, Panickar KS, Majid A. Asiatic acid, a pentacyclic triterpene from Centella asiatica, is neuroprotective in a mouse model of focal cerebral ischemia. J Neurosci Res, 87(11):2541-50, 2009.
